kanamycin a has been researched along with Cystic Fibrosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (93.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, C; Liu, Y; Ma, C; Ma, L; Sun, W; Xu, P; Xu, R; Yang, C | 1 |
| MANLAPAS, FC; OPALKA, E; PATTERSON, P; SOIKE, K; STEIN, AA | 1 |
| Aronoff, SC; Klinger, JD | 1 |
| Baran, D; Klastersky, J; Levy, J | 1 |
| Boxerbaum, B; Demko, CA; Kuchenbrod, PJ; Stern, RC; Thomassen, MJ | 1 |
| Hoogkamp-Korstanje, JA; Westerdaal, NA | 1 |
| Dooley, RR; Lau, WK; Osher, AB; Young, LS | 1 |
| Finkelstein, E; Hall, K | 1 |
| Kowarski, A; Lietman, PS; Vogelstein, B | 1 |
| Cournol, R; Delnatte, J; Loeuille, GA; Martin, G | 1 |
| Chadwick, EG; Shulman, ST; Yogev, R | 1 |
| Courcol, RJ; Delnatte, J; Loeuille, GA; Martin, GR | 1 |
| Denning, CR; Kutscher, AH; Ragosta, JM; Zegarelli, EV | 1 |
| Ahl, LA; Fisher, MW; Muschel, LH | 1 |
| Calandi, C; Vichi, GF | 1 |
1 trial(s) available for kanamycin a and Cystic Fibrosis
| Article | Year |
|---|---|
Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Cystic Fibrosis; Humans; Kanamycin; Kinetics; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1982 |
14 other study(ies) available for kanamycin a and Cystic Fibrosis
| Article | Year |
|---|---|
Metabolic Mechanism and Physiological Role of Glycerol 3-Phosphate in Pseudomonas aeruginosa PAO1.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Glycerol; Humans; Kanamycin; Oxidoreductases; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
LIPID PATTERNS OF ANTIBIOTIC RESISTANT AND SENSITIVE STRAINS OF STAPHYLOCOCCUS AUREUS ASSOCIATED WITH CYSTIC FIBROSIS OF THE PANCREAS.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Chloramphenicol; Chromatography; Cystic Fibrosis; Drug Resistance, Microbial; Erythromycin; Fatty Acids; Humans; Kanamycin; Lipid Metabolism; Lipids; Neomycin; Penicillin Resistance; Sputum; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus Phages; Tetracycline | 1965 |
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Child; Cystic Fibrosis; Drug Therapy, Combination; Humans; Kanamycin; Penicillin Resistance; Piperacillin; Pseudomonas Infections; Ticarcillin | 1984 |
Multiple of isolates of Pseudomonas aeruginosa with differing antimicrobial susceptibility patterns from patients with cystic fibrosis.
Topics: Adolescent; Adult; Carbenicillin; Child; Child, Preschool; Cystic Fibrosis; Gentamicins; Humans; Infant; Kanamycin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tetracycline; Ticarcillin; Time Factors; Tobramycin | 1979 |
In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
Topics: Amikacin; Aminoglycosides; Ampicillin; Carbenicillin; Cephalothin; Child; Colistin; Cystic Fibrosis; Gentamicins; Humans; Kanamycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pseudomonas; Sputum; Tobramycin | 1979 |
Amikacin therapy of exacerbations of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Topics: Acute Disease; Adolescent; Adult; Amikacin; Child; Child, Preschool; Cystic Fibrosis; Female; Humans; Kanamycin; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1977 |
Aminoglycoside clearance in patients with cystic fibrosis.
Topics: Amikacin; Child; Cystic Fibrosis; Humans; Kanamycin; Kidney | 1979 |
The pharmacokinetics of amikacin in children.
Topics: Adolescent; Amikacin; Anemia, Aplastic; Appendicitis; Child; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Kanamycin; Kidney; Leukemia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Pelvic Inflammatory Disease | 1977 |
[Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population].
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Dibekacin; Female; Humans; Kanamycin; Male; Ticarcillin | 1987 |
Combination antibiotic therapy in pediatrics.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Cystic Fibrosis; Drug Synergism; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infant; Infant, Newborn; Kanamycin; Lactams; Neutropenia; Peritoneal Dialysis, Continuous Ambulatory; Pseudomonas Infections; Risk | 1986 |
Pharmacokinetics of dibekacin in children with cystic fibrosis.
Topics: Aspartate Aminotransferases; Child; Creatinine; Cystic Fibrosis; Dibekacin; Humans; Kanamycin; Kinetics; Time Factors | 1985 |
Discoloration of the teeth in a 24-year-old patient with cystic fibrosis of the pancreas not primarily associated with tetracycline therapy. Report of a case.
Topics: Adult; Bronchopneumonia; Chloramphenicol; Cystic Fibrosis; Erythromycin; Female; Humans; Kanamycin; Penicillins; Polymyxins; Streptomycin; Tetracycline; Tooth Discoloration | 1967 |
Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.
Topics: Animals; Blood; Blood Bactericidal Activity; Chloramphenicol; Chlortetracycline; Cystic Fibrosis; Dactinomycin; Detergents; Erythromycin; Guinea Pigs; Humans; Immune Sera; Kanamycin; Mitomycins; Penicillins; Polymyxins; Pseudomonas; Pseudomonas aeruginosa; Temperature | 1969 |
[Bronchiectases secondary to cystic fibrosis in childhood].
Topics: Bronchiectasis; Carbenicillin; Child; Child, Preschool; Chloramphenicol; Cystic Fibrosis; Drainage; Female; Humans; Infant; Infant, Newborn; Kanamycin; Male; Streptomycin | 1972 |